May 31, 2017 Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
May 22, 2017 miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
April 21, 2017 Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
October 3, 2017 Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards Development March 10, 2017 Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ Overview and Objectives The Coalition Against Major Diseas
February 1, 2017 A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
April 25, 2017 Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Event: Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Date: April 25, 2017 Location: Hyatt Rege
January 1, 2017 Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
April 11, 2016 Electronic Capture of Clinical Outcome Assessment Data: Why Is It Not Used More in Clinical Studies
October 25, 2016 TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research Oct 25, 2016 TB-ReFLECT: A Collaborative Effort to Enhance TB Clinical Research TUCSON, Ariz., October 25, 2016 —
April 26, 2016 Workshop on Clinical Outcome Assessments (COAs) in Cancer Clinical Trials(old) Workshop on Clinical Outcome Assessments (COAs) in Cancer Clinical Trials April 26, 2016 Sheraton Silver Spring Hotel 8777 Georgia
